Where Will Epizyme Be in 1 Year?

Although shares of Epizyme (NASDAQ: EPZM) are trading at a fraction of the all-time high achieved shortly after the initial public offering in 2013, the company's current market valuation of $1.2 billion is close to a high-water mark. Investors can thank a surge in stock dilution (which keeps the market cap elevated) as well as signs of tangible progress (which have sent shares soaring recently).